These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7222836)

  • 1. [20 years of ulcerative colitis treatment. Retrospective study from the point of view of a medical clinic].
    Fiedler H
    Z Gesamte Inn Med; 1980 Dec; 35(24):890-3. PubMed ID: 7222836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enteral nutrition in severe ulcerative colitis. Digestive tolerance and nutritional efficiency].
    Klaassen J; Zapata R; Mella JG; Aguayo G; Alvarado D; Espinosa O; Maíz A; Zúñiga A; Quintana C
    Rev Med Chil; 1998 Aug; 126(8):899-904. PubMed ID: 9830740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
    Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T
    Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.
    González-Huix F; Fernández-Bañares F; Esteve-Comas M; Abad-Lacruz A; Cabré E; Acero D; Figa M; Guilera M; Humbert P; de León R
    Am J Gastroenterol; 1993 Feb; 88(2):227-32. PubMed ID: 8424426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
    Jo Y; Matsumoto T; Mibu R; Iida M
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.
    Okada H; Takenaka R; Hiraoka S; Makidono C; Hori S; Kato J; Okazaki H; Kawamoto H; Mizuno M; Shiratori Y
    Ther Apher Dial; 2006 Jun; 10(3):242-6. PubMed ID: 16817788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple organ dysfunction in ulcerative colitis.
    Caprilli R; Latella G; Vernia P; Frieri G
    Am J Gastroenterol; 2000 May; 95(5):1258-62. PubMed ID: 10811337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    Colorectal Dis; 2006 Sep; 8(7):551-6. PubMed ID: 16919105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival rate and prognostic factors in patients with intestinal failure.
    Vantini I; Benini L; Bonfante F; Talamini G; Sembenini C; Chiarioni G; Maragnolli O; Benini F; Capra F
    Dig Liver Dis; 2004 Jan; 36(1):46-55. PubMed ID: 14971815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinicomorphological characterization of segmental lesion in ulcerous colitis].
    Vorob'ev GI; Khalif IL; Malakhova NS; Kapuller LL; Vasil'chenko AV; Mikhaĭlova TL; Golovenko OV
    Klin Med (Mosk); 2007; 85(1):44-7. PubMed ID: 17419355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cholecystitis after colectomy for ulcerative colitis.
    García Picazo D; Bermúdez Rodríguez E; Moreno Resina JM
    Rev Esp Enferm Dig; 2000 Jun; 92(6):392-8. PubMed ID: 10985099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency and predictive factors of colectomy and restorative colo-proctectomy in ulcerative colitis].
    Karoui S; Serghini M; Chaieb M; Jomni T; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2009 Feb; 87(2):115-9. PubMed ID: 19522443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic inflammatory bowel disease with special reference to ulcerative colitis in apparently healthy persons.
    Sakata T; Niwa Y; Goto H; Hirooka Y; Hayakawa T; Ohmiya N; Kobayashi S
    Am J Gastroenterol; 2001 Mar; 96(3):735-9. PubMed ID: 11280543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for operation in ulcerative colitis in the era of the pouch and before.
    Mikkola KA
    Eur J Surg; 1997 Feb; 163(2):129-34. PubMed ID: 9076440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis in pancolonic forms of hemorrhagic rectocolitis].
    Nkontchou G; Cosnes J; Carbonnel F; Beaugerie L; Ngô Y; Malafosse M; Gendre JP; Le Quintrec Y
    Gastroenterol Clin Biol; 1996 Mar; 20(2):166-71. PubMed ID: 8761676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.